(0.19%) 5 141.00 points
(0.19%) 38 513 points
(0.25%) 17 891 points
(-0.93%) $83.07
(1.56%) $1.953
(-0.34%) $2 339.20
(-0.31%) $27.45
(0.26%) $924.50
(-0.13%) $0.934
(-0.06%) $11.02
(-0.20%) $0.799
(0.86%) $92.67
0.00% HKD 0.560
Live Chart Being Loaded With Signals
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China...
Stats | |
---|---|
Dagens volum | 13.57M |
Gjennomsnittsvolum | 7.60M |
Markedsverdi | 5.20B |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.0370 ( 2023-06-06 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -56.00 |
ATR14 | HKD0.00100 (0.18%) |
Volum Korrelasjon
Sihuan Pharmaceutical Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Sihuan Pharmaceutical Korrelasjon - Valuta/Råvare
Sihuan Pharmaceutical Økonomi
Annual | 2023 |
Omsetning: | HKD1.86B |
Bruttogevinst: | HKD1.30B (69.64 %) |
EPS: | HKD-0.00580 |
FY | 2023 |
Omsetning: | HKD1.86B |
Bruttogevinst: | HKD1.30B (69.64 %) |
EPS: | HKD-0.00580 |
FY | 2022 |
Omsetning: | HKD2.18B |
Bruttogevinst: | HKD1.49B (68.20 %) |
EPS: | HKD-0.210 |
FY | 2021 |
Omsetning: | HKD3.29B |
Bruttogevinst: | HKD2.45B (74.39 %) |
EPS: | HKD0.0440 |
Financial Reports:
No articles found.
Sihuan Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0360 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0370 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0390 | 2011-09-21 |
Last Dividend | HKD0.0370 | 2023-06-06 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 23 | -- |
Total Paid Out | HKD0.764 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.03 | -- |
Div. Sustainability Score | 3.27 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.991 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
87001.HK | Ex Dividend Junior | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
2107.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
1114.HK | Ex Dividend Junior | 2023-08-11 | Annually | 0 | 0.00% | |
0189.HK | Ex Dividend Junior | 2023-06-14 | Annually | 0 | 0.00% | |
3808.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
1696.HK | Ex Dividend Junior | 2023-08-24 | Annually | 0 | 0.00% | |
0730.HK | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
2283.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
1270.HK | Ex Dividend Knight | 2023-05-16 | Annually | 0 | 0.00% | |
0323.HK | No Dividend Player | 2023-06-21 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0290 | 1.500 | -0.581 | -0.871 | [0 - 0.5] |
returnOnAssetsTTM | -0.00468 | 1.200 | -0.156 | -0.187 | [0 - 0.3] |
returnOnEquityTTM | -0.0122 | 1.500 | -1.247 | -1.870 | [0.1 - 1] |
payoutRatioTTM | -5.53 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.511 | 0.800 | 7.45 | 5.96 | [1 - 3] |
quickRatioTTM | 1.160 | 0.800 | 7.88 | 6.30 | [0.8 - 2.5] |
cashRatioTTM | 0.920 | 1.500 | 6.00 | 9.00 | [0.2 - 2] |
debtRatioTTM | 0.106 | -1.500 | 8.23 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00318 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00510 | 2.00 | -0.00255 | -0.00510 | [0 - 20] |
debtEquityRatioTTM | 0.277 | -1.500 | 8.89 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.696 | 1.000 | 1.727 | 1.727 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0736 | 1.000 | -3.47 | -3.47 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0231 | 1.000 | -0.983 | -0.983 | [0.2 - 2] |
assetTurnoverTTM | 0.161 | 0.800 | -2.26 | -1.806 | [0.5 - 2] |
Total Score | 3.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -85.44 | 1.000 | -8.73 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0122 | 2.50 | -0.802 | -1.870 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00510 | 2.00 | -0.00170 | -0.00510 | [0 - 30] |
dividendYielPercentageTTM | 7.14 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00318 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | -5.53 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | -0.934 | 1.500 | -9.56 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0152 | 1.000 | -2.12 | 0 | [0.1 - 0.5] |
Total Score | -1.286 |
Sihuan Pharmaceutical
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.